Copyright Reports & Markets. All rights reserved.

Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Growth 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption 2014-2024
        • 2.1.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption CAGR by Region
      • 2.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Segment by Type
        • 2.2.1 5-HT3 Inhibitors
        • 2.2.2 NK1 Inhibitors
        • 2.2.3 Other
      • 2.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Type
        • 2.3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale Price by Type (2014-2019)
      • 2.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Segment by Application
        • 2.4.1 Highly Emetogenic Chemotherapy
        • 2.4.2 Moderately Emetogenic Chemotherapy
        • 2.4.3 Low Emetogenic Chemotherapy
        • 2.4.4 Other
      • 2.5 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Application
        • 2.5.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale Price by Application (2014-2019)

      3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Players

      • 3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Players
        • 3.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Players (2017-2019)
        • 3.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Players (2017-2019)
      • 3.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Players
        • 3.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Players (2017-2019)
        • 3.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Players (2017-2019)
      • 3.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale Price by Players
      • 3.4 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Regions

      • 4.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Regions
        • 4.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Regions
        • 4.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Value by Regions
      • 4.2 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Growth
      • 4.3 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Growth
      • 4.4 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Growth
      • 4.5 Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Growth

      5 Americas

      • 5.1 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Countries
        • 5.1.1 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Countries (2014-2019)
        • 5.1.2 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Value by Countries (2014-2019)
      • 5.2 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Type
      • 5.3 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Countries
        • 6.1.1 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Countries (2014-2019)
        • 6.1.2 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Value by Countries (2014-2019)
      • 6.2 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Type
      • 6.3 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Countries
        • 7.1.1 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Countries (2014-2019)
        • 7.1.2 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Value by Countries (2014-2019)
      • 7.2 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Type
      • 7.3 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Countries
        • 8.1.1 Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Type
      • 8.3 Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Distributors
      • 10.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Customer

      11 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Forecast

      • 11.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2019-2024)
      • 11.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Forecast by Regions
        • 11.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Forecast by Regions (2019-2024)
        • 11.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Forecast by Type
      • 11.8 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Forecast by Application

      12 Key Players Analysis

      • 12.1 Merck
        • 12.1.1 Company Details
        • 12.1.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered
        • 12.1.3 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Merck News
      • 12.2 Eisai
        • 12.2.1 Company Details
        • 12.2.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered
        • 12.2.3 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Eisai News
      • 12.3 Mundipharma
        • 12.3.1 Company Details
        • 12.3.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered
        • 12.3.3 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Mundipharma News
      • 12.4 Qilu Pharma
        • 12.4.1 Company Details
        • 12.4.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered
        • 12.4.3 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Qilu Pharma News
      • 12.5 Teva
        • 12.5.1 Company Details
        • 12.5.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered
        • 12.5.3 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Teva News
      • 12.6 Novartis
        • 12.6.1 Company Details
        • 12.6.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered
        • 12.6.3 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Novartis News
      • 12.7 Heron Therapeutics
        • 12.7.1 Company Details
        • 12.7.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered
        • 12.7.3 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Heron Therapeutics News
      • 12.8 Roche
        • 12.8.1 Company Details
        • 12.8.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered
        • 12.8.3 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Roche News
      • 12.9 Mylan
        • 12.9.1 Company Details
        • 12.9.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered
        • 12.9.3 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 Mylan News
      • 12.10 Tesaro
        • 12.10.1 Company Details
        • 12.10.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered
        • 12.10.3 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 Tesaro News

      13 Research Findings and Conclusion

      Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families.
      The classification of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs includes 5-HT3 Inhibitors, NK1 Inhibitors and others. The proportion of 5-HT3 Inhibitors in 2017 is about 62%, and the proportion of NK1 Inhibitors in 2017 is about 33%.
      Chemotherapy Induced Nausea and Vomiting (CINV) Drugs are application for Highly Emetogenic Chemotherapy, Moderately Emetogenic Chemotherapy, Low Emetogenic Chemotherapy and others. The most of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs is used for Moderately Emetogenic Chemotherapy, and the market share of that is about 52 % in 2017.

      According to this study, over the next five years the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market will register a 5.9% CAGR in terms of revenue, the global market size will reach US$ 96 million by 2024, from US$ 72 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Chemotherapy Induced Nausea and Vomiting (CINV) Drugs business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares, and growth opportunities of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market by product type, application, key manufacturers and key regions and countries.

      This study considers the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs value and volume generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
      5-HT3 Inhibitors
      NK1 Inhibitors
      Other
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
      Highly Emetogenic Chemotherapy
      Moderately Emetogenic Chemotherapy
      Low Emetogenic Chemotherapy
      Other

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      Merck
      Eisai
      Mundipharma
      Qilu Pharma
      Teva
      Novartis
      Heron Therapeutics
      Roche
      Mylan
      Tesaro

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market by identifying its various subsegments.
      Focuses on the key global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the consumption of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now